Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02516709 · ClinicalTrials.gov registry record
Linear Source Registry for Prostate Cancer
A clinical trial, sponsored by CivaTech Oncology.
- Completed
- Registry status
- 60
- Enrollment target
NCT02516709: Completed study, sponsored by CivaTech Oncology.
NCT02516709 is a clinical trial that has completed, run by CivaTech Oncology. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02516709 has completed, sponsored by CivaTech Oncology.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.
Interventions
- RADIATION Linear LDR Source
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-06 |
| Est. Completion | 2023-06 |
What the finished NCT02516709 record still lists
NCT02516709 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Linear LDR Source is the first listed.
NCT02516709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02516709 about?
NCT02516709 is a clinical study titled "Linear Source Registry for Prostate Cancer". Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.
What is the current status of trial NCT02516709?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2015-06. Estimated completion is 2023-06.
What interventions are being tested in trial NCT02516709?
The interventions under investigation include: Linear LDR Source (RADIATION).
Who is sponsoring clinical trial NCT02516709?
This trial is sponsored by CivaTech Oncology, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia